Is brensocatib under FDA Priority Review in 2026?
Brensocatib’s FDA Priority Review status for 2026 is not confirmed in the information provided here. To verify the exact status and the expected review timeline, you need to check FDA’s current Priority Review announcements or the drug’s FDA action package/status in 2026.
How can I check whether brensocatib got Priority Review (and for which application)?
For Priority Review, the most reliable places to look are:
- FDA Priority Review program postings and Priority Review announcements tied to specific marketing applications.
- FDA press releases or updates for brensocatib’s application review status in the relevant approval year.
- FDA drug product pages that track review milestones and action dates (when available for the specific application).
What “Priority Review” changes for a drug like brensocatib?
Priority Review changes the FDA’s target review timeline (it aims to shorten the review period compared with standard review). The practical outcome is earlier FDA decision-making relative to standard timelines, assuming the application is complete and proceeds through review without major delays.
If Priority Review is granted, when would a decision typically happen?
Priority Review typically targets a shorter FDA decision window than standard review. Exact dates depend on when FDA formally accepts the application and when the review cycle starts for that specific submission.
What to check if you want the 2026 timeline (not just the label)?
Even if an applicant received Priority Review, the final “decision date” can shift due to:
- Application completeness and filing timing.
- Additional information requests (often captured through FDA review communications).
- Advisory committee schedules (if one applies for that indication).
- Labeling negotiations and post-marketing commitments.
If you’re asking for the latest 2026 status: what details do you need?
To give a precise answer, tell me one of the following:
- the FDA application/indication you mean (e.g., non-CF bronchiectasis vs another use),
- the FDA application number (if you have it),
- or whether you want the “priority review” decision date or the expected PDUFA/target action date for 2026.
If you share any link or the specific FDA announcement you’re looking at, I can interpret it and extract the priority-review status and the associated 2026 timeline.